Delaying b-cell depleters (Ocrevus, kesimpta, rituximab) increases the chance of getting protective antibodies after covid-19 vaccination

source

Pin
  1. Delaying b-cell depleters (Ocrevus, kesimpta, rituximab) increases the chance of gettin...
Notice label will go here